Note: Ingredients listed on restricted chemical lists
EC/CAS
203-740-4/110-15-6
Name of the chemical
succinic acid
Concentration
>=3-<10
General Information
Version
1.0
Revision date
2018-05-08
Product name
Zactran , Injectable solution (finished product)
Product Synonyms
Zactran®, 150 mg/ml Solution for Injection for Cattle, Zactran swine, Zactran PP with API: Gamythromycin
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user on use
Emergency telephone
+498007790900, +1 703-527-3887
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H361fd
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H318 Causes serious eye damage. H361fd Suspected of damaging fertility. Suspected of damag- ing the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if pre- sent and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
1,3-Dioxan-5-ol, 1,3-Dioxolan-4-ylmethanol Gamithromycin Succinic acid
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Serious eye damage , Category 1 H318: Causes serious eye damage. Reproductive toxicity , Category 2 H361fd: Suspected of damaging fertility. Suspected of damaging the unborn child.
